This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (403) Substance Abuse (530) ePrescribing and Innovations in Pharmacies (84)

Published on in Vol 11, No 10 (2022): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/42373, first published .
The PharmNet Harm Reduction Intervention for Community Pharmacies: Protocol for a Pilot Randomized Controlled Trial

The PharmNet Harm Reduction Intervention for Community Pharmacies: Protocol for a Pilot Randomized Controlled Trial

The PharmNet Harm Reduction Intervention for Community Pharmacies: Protocol for a Pilot Randomized Controlled Trial

Authors of this article:

Lori Ann Eldridge1 Author Orcid Image ;   Jon Agley2 Author Orcid Image ;   Beth E Meyerson3, 4 Author Orcid Image ;   Lilian Golzarri-Arroyo5 Author Orcid Image
Article Authors Cited by (3) Tweetations (9) Metrics

Journals

  1. Eldridge L, Meyerson B, Agley J. Implementation Documentation and Process Assessment of the PharmNet Intervention: Observational Report. JMIR Formative Research 2024;8:e54077 View
  2. Meyerson B, Agley J, Crosby R, Bentele K, Vadiei N, Linde-Krieger L, Russell D, Fine K, Eldridge L. ASAP: A pharmacy-level intervention to increase nonprescription syringe sales to reduce bloodborne illnesses. Research in Social and Administrative Pharmacy 2024;20(8):778 View
  3. Meyerson B, Linde-Krieger L, Agley J, Vadiei N, Crosby R, Bentele K. Access to syringes at pharmacies (ASAP): Preliminary impact of a pharmacy-level intervention. Journal of the American Pharmacists Association 2026;66(1):102947 View